ES2096440T3 - Nuevo procedimiento para la preparacion de derivados del taxano, nuevos derivados asi obtenidos y las composiciones que les contienen. - Google Patents

Nuevo procedimiento para la preparacion de derivados del taxano, nuevos derivados asi obtenidos y las composiciones que les contienen.

Info

Publication number
ES2096440T3
ES2096440T3 ES94900862T ES94900862T ES2096440T3 ES 2096440 T3 ES2096440 T3 ES 2096440T3 ES 94900862 T ES94900862 T ES 94900862T ES 94900862 T ES94900862 T ES 94900862T ES 2096440 T3 ES2096440 T3 ES 2096440T3
Authority
ES
Spain
Prior art keywords
new
derivatives
ethyl
preparation
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94900862T
Other languages
English (en)
Inventor
Herve Bouchard
Jean-Dominique Bouzart
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2096440T3 publication Critical patent/ES2096440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NUEVO PROCESO DE PREPARACION DE DERIVADOS DEL TAXANO DE FORMULA (I) Y LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS NUEVOS DERIVADOS ASI OBTENIDOS. EN LA FORMULA GENERAL (I), R REPRESENTA HIDROGENO O ACETILO, O R1 REPRESENTA BENZOILO O R2-OCO EN EL QUE R2 REPRESENTA ALCOILO, ALCENILO, ALCINILO, CICLOALCOILO, CICLOALCENILO, BICICLOALCOILO, FENILO O HETEROCICLILO Y HET REPRESENTA UN HETEROCICLO AROMATICO DE 5 ESLABONES (TIOFENO TIAZOL, FURANO PIROL, IMIDAZOL, OXAZOL, ISOXAZOL, PIRAZOL) EVENTUALMENTE SUSTITUIDO. LOS NUEVOS PRODUCTOS DE FORMULA (I) PRESENTAN PROPIEDADES ANTITUMORALES Y ANTILEUCEMICAS NOTABLES.
ES94900862T 1992-11-23 1993-11-22 Nuevo procedimiento para la preparacion de derivados del taxano, nuevos derivados asi obtenidos y las composiciones que les contienen. Expired - Lifetime ES2096440T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214023A FR2698363B1 (fr) 1992-11-23 1992-11-23 Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.

Publications (1)

Publication Number Publication Date
ES2096440T3 true ES2096440T3 (es) 1997-03-01

Family

ID=9435782

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94900862T Expired - Lifetime ES2096440T3 (es) 1992-11-23 1993-11-22 Nuevo procedimiento para la preparacion de derivados del taxano, nuevos derivados asi obtenidos y las composiciones que les contienen.

Country Status (23)

Country Link
US (1) US5606083A (es)
EP (1) EP0669916B1 (es)
JP (1) JPH08503486A (es)
KR (1) KR950704286A (es)
AT (1) ATE148111T1 (es)
AU (1) AU680455B2 (es)
CA (1) CA2149758A1 (es)
CZ (1) CZ131795A3 (es)
DE (1) DE69307730T2 (es)
DK (1) DK0669916T3 (es)
ES (1) ES2096440T3 (es)
FI (1) FI952482A (es)
FR (1) FR2698363B1 (es)
GR (1) GR3022359T3 (es)
HU (1) HUT74069A (es)
NO (1) NO952017D0 (es)
NZ (1) NZ258144A (es)
PL (1) PL309037A1 (es)
RU (1) RU95113421A (es)
SK (1) SK68195A3 (es)
TW (1) TW254938B (es)
WO (1) WO1994012484A1 (es)
ZA (1) ZA938728B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698582A (en) * 1991-07-08 1997-12-16 Rhone-Poulenc Rorer S.A. Compositions containing taxane derivatives
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5677470A (en) 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
CA2170661A1 (en) * 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
ATE234800T1 (de) 1997-08-21 2003-04-15 Univ Florida State Verfahren zur synthese von taxanen
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
DE60327651D1 (de) * 2002-10-09 2009-06-25 Chatham Biotec Ltd Thio-analoga von paclitaxel und deren vorprodukte
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
FR2986526A1 (fr) * 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
FR2698363B1 (fr) 1994-12-30
AU680455B2 (en) 1997-07-31
JPH08503486A (ja) 1996-04-16
AU5565994A (en) 1994-06-22
US5606083A (en) 1997-02-25
EP0669916B1 (fr) 1997-01-22
FI952482A0 (fi) 1995-05-22
ZA938728B (en) 1994-06-28
CA2149758A1 (fr) 1994-06-09
WO1994012484A1 (fr) 1994-06-09
NO952017L (no) 1995-05-22
RU95113421A (ru) 1997-03-20
FR2698363A1 (fr) 1994-05-27
EP0669916A1 (fr) 1995-09-06
PL309037A1 (en) 1995-09-18
FI952482A (fi) 1995-05-24
CZ131795A3 (en) 1995-10-18
DK0669916T3 (da) 1997-02-10
NO952017D0 (no) 1995-05-22
NZ258144A (en) 1996-10-28
ATE148111T1 (de) 1997-02-15
KR950704286A (ko) 1995-11-17
DE69307730D1 (de) 1997-03-06
GR3022359T3 (en) 1997-04-30
HU9501500D0 (en) 1995-07-28
SK68195A3 (en) 1995-10-11
DE69307730T2 (de) 1997-06-05
HUT74069A (en) 1996-10-28
TW254938B (es) 1995-08-21

Similar Documents

Publication Publication Date Title
ES2096440T3 (es) Nuevo procedimiento para la preparacion de derivados del taxano, nuevos derivados asi obtenidos y las composiciones que les contienen.
AR003455A1 (es) Derivados tetraciclicos, su uso en la preparacion de un medicamento, un metodo de tratamiento, una composicion farmaceutica y procesos para lapreparacion de una composicion farmaceutica y para preparar los compuestos.
DE59103595D1 (de) Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel.
MX9400206A (es) Derivados de vinil-azaindol, proceso para su preparacion y composiciones farmaceuticas que los contienen.
ES2154674T3 (es) Derivados de 1,5-benzodiacepinas con actividad antagonista o agonista de cck.
DK0528734T3 (da) Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
MX9200344A (es) Derivados de benzamida, proceso para su preparacion y composicion farmaceutica que los contiene.
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
AR010700A1 (es) Derivados de purina sustituidos, procedimiento para su preparacion, su empleo y su agente que los contiene
FI962952A (fi) Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
AR029942A1 (es) Compuestos derivados de 1,3-dihidro-2h-indol-2-ona, su utilizacion, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden, medicamentos constituidos por dichos compuestos y compuestos intermediarios
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
AR002041A1 (es) Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.
DE69229339T2 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
ES2133418T3 (es) Procedimiento para la preparacion de derivados del taxano.
ES2067874T3 (es) Derivados de acetamida.
FI894061A (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
ES2155621T3 (es) Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.
DE3775319D1 (de) Imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES2088241T3 (es) Nuevos esteroides que comprenden en posicion 17 un radical metileno-lactona, su procedimiento y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ES2071458T3 (es) Nuevos compuestos amidicos de 1-(alcoxi-bencil)-piperacinas, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 669916

Country of ref document: ES